Equity
€67,547 ▲ 7.2%
Injection Test paid out €8,000 in dividends. That is 64% of the 2025 profit.
Injection Test
Lifetime
6 annual accounts with figures on one time axispeak €69,171 (2024)
€35,456▼ 48.7%
peak €34,531 (2023)
€12,518▲ 362%
peak €68,319 (2023)
€67,547▲ 7.2%
€25,056▼ 13.6%
Board2 names since 2019
2 directors and 1 other
Documentsfilings and deeds
18-02-2026163 days before the deadline
2025micro format
Gross margin from €69,171 to €35,456Result from €2,710 to €12,518Registered office moved from Oupeye to Heure-Le-Romain 22-12Dividend €8,000Cash from €86,935 to €35,861
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,969 companies had the same profile as Injection Test has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.4%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,969 companies, not a prediction for Injection Test. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 22-11-2019
Director, since 22-11-2019
- founderdeed of 27-11-2019
- founderdeed of 27-11-2019
Recent changes
Registered office moved from Oupeye to Heure-Le-Romain
New registered office: Rue Boyou 52-4682 HEURE-LE-ROMAIN · Previous registered office: rue Haut-Vinâve 63 Boîte bis, 4682 OUPEYE · General meeting of 31-10-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0737987282
First establishment
Rue Boyou 52, Oupeye
Incorporation
Founding capital of €5,000, 100 shares · Founders: and · Appointments: (director) and (director) · published on 27-11-2019 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Injection Test Oupeye | €92,603 | €35,456 | 72.9% | - |
| OCEWOOD Benelux Antwerp | €70,646 | €30,314 | -51.2% | - |
| VANDECASTEELE BRAM ENGINEERING Lievegem | €111,139 | €75,099 | 26.3% | - |
| TRIPOLY Harelbeke | €468,522 | €46,558 | 37.9% | 0 |
| A PRIORI PLASTICS Lummen | €548,697 | €79,383 | 64.3% | - |
| FAM. COOSEMANS Hoeilaart | €405,067 | €75,107 | 84.1% | - |
| REBOPLAST Tielt | €177,608 | €25,292 | -136.6% | - |
These companies have the same main activity as Injection Test: manufacture of chemicals and chemical products (NACE 20160). They are comparable in size and age: total assets between €70,600 and €549,000, founded between 2009 and 2022.
Official details
Source: KBO- Status
- Active since 22-11-2019Normal situation
- Activity
- Manufacture of chemicals and chemical productsNACE 20160and 1 other
- Establishment unit
- 2.296.362.6574682 Oupeye, since 01-12-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 23-10-2025
Annual accounts 2025
- €92,603▼ 35.5%
- Employeeson 31-12-2025
- 0
- Filing
- Filed on 18-02-2026, 163 days before the end of the filing period
Insights on Injection Test
Injection Test files the micro format. That format states no turnover. The gross margin fell from €36,087 in 2020 to €35,456 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Injection Test
- What is the company number of Injection Test?
- The company number of Injection Test is 0737.987.282. The VAT number is the same number with BE in front: BE 0737.987.282.
- Where is Injection Test based?
- The registered office is at Rue Boyou 52, 4682 Oupeye.Company details
- What does Injection Test do?
- According to the KBO register, the main activity is manufacture of chemicals and chemical products (NACE 20160).
- What is the legal form of Injection Test?
- Injection Test is a private limited company (BV).
- When was Injection Test founded?
- Injection Test was founded on 22-11-2019.
- Is Injection Test still active?
- Yes, Injection Test is an active enterprise in the KBO register.
- What is the turnover of Injection Test?
- The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €35,456 and 2,936 comparable companies of the same size. It probably lies between €86,000 and €260,000. It is a rough estimate. In financial year 2023 turnover was €0.Financials
- Is Injection Test profitable?
- In financial year 2025, Injection Test made a profit of €12,518.
- Where can I find the annual accounts of Injection Test?
- Injection Test filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Injection Test due?
- Injection Test must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.